13 Best German Stocks to Invest in Now

Page 6 of 12

7. InflaRx N.V. (NASDAQ:IFRX)

Number of Hedge Fund Holders: 11

InflaRx N.V. (NASDAQ:IFRX) is among the 13 Best German Stocks to Invest in Now, based on hedge fund sentiment. However, the stock has plunged by 67% year-to-date, with a significant slump over the past month, following the company’s announcement on May 28 to halt its Phase 3 trial for vilobelimab in pyoderma gangrenosum (PG) due to futility.

The clinical-stage biopharmaceutical company said that it decided on the recommendation of the Independent Data Monitoring Committee (IDMC), based on the data analysis of the first 30 patients in the study.

Prof. Niels C. Riedemann, Chief Executive Officer and Founder of InflaRx N.V. (NASDAQ:IFRX) stated the following on the decision:

“We would like to thank the dedicated physicians and pyoderma gangrenosum patients for their participation in this pioneering study targeting a significant unmet need. While the outcome is not what we had hoped it would be, InflaRx remains committed to its goal of developing new therapies for underserved patients with chronic immune-dermatological conditions, including with our oral inhibitor of C5aR, INF904, with data expected this summer.”

InflaRx N.V. (NASDAQ:IFRX) has discontinued further development of vilobelimab in PG. Instead, it will prioritize its resources on the Phase 2a trial of INF904 to treat hidradenitis suppurativa and chronic spontaneous urticaria.

Page 6 of 12